Jacobs Levy Equity Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-85,849
| Closed | -$3.39M | – | 1162 |
|
|
2025
Q1 | $3.39M | Buy |
85,849
+1,260
| +1% | +$49.7K | 0.01% | 550 |
|
|
2024
Q4 | $2.55M | Sell |
84,589
-95,749
| -53% | -$2.88M | 0.01% | 550 |
|
|
2024
Q3 | $4.22M | Hold |
180,338
| – | – | 0.02% | 468 |
|
|
2024
Q2 | $3.21M | Sell |
180,338
-344,523
| -66% | -$6.13M | 0.01% | 514 |
|
|
2024
Q1 | $7.98M | Buy |
524,861
+120,699
| +30% | +$1.84M | 0.04% | 337 |
|
|
2023
Q4 | $6.9M | Sell |
404,162
-1,456
| -0.4% | -$24.9K | 0.03% | 364 |
|
|
2023
Q3 | $3.39M | Buy |
405,618
+145,667
| +56% | +$1.22M | 0.02% | 451 |
|
|
2023
Q2 | $6.46M | Hold |
259,951
| – | – | 0.04% | 340 |
|
|
2023
Q1 | $3.91M | Sell |
259,951
-107,522
| -29% | -$1.62M | 0.02% | 454 |
|
|
2022
Q4 | $4.35M | Buy |
367,473
+254,978
| +227% | +$3.02M | 0.03% | 420 |
|
|
2022
Q3 | $666K | Buy |
+112,495
| New | +$666K | 0.01% | 787 |
|
|
2020
Q3 | – | Sell |
-23,900
| Closed | -$466K | – | 1107 |
|
|
2020
Q2 | $466K | Sell |
23,900
-1,501
| -6% | -$29.3K | 0.01% | 801 |
|
|
2020
Q1 | $250K | Sell |
25,401
-143,799
| -85% | -$1.42M | ﹤0.01% | 848 |
|
|
2019
Q4 | $1.88M | Buy |
169,200
+48,800
| +41% | +$542K | 0.02% | 557 |
|
|
2019
Q3 | $676K | Buy |
120,400
+12,400
| +11% | +$69.6K | 0.01% | 672 |
|
|
2019
Q2 | $934K | Buy |
+108,000
| New | +$934K | 0.01% | 653 |
|
|
2018
Q3 | – | Sell |
-26,710
| Closed | -$351K | – | 1071 |
|
|
2018
Q2 | $351K | Buy |
+26,710
| New | +$351K | 0.01% | 869 |
|